EPHB2 and deep vein thrombosis: In addition, we found that a greater proportion of patients with thrombosis than patients without thrombosis carried EpHB2 mutations (p = 0.015), SWAP70 mutations (p = 0.039), ABCA13 mutations (p = 0.01) and SLC15A4 mutations (p = 0.004).